History of treatment and long-term outcome in children with acute lymphoblastic leukemia in the Czech Republic

Memo - Magazine of European Medical Oncology

Volumn 4, Issue 3, 2011, Pages 196-201

  Stary J ^a   Mihal V ^b   Smisek P ^a   Blazek B ^c   Jabali, Y ^d   Hrstkova H ^e   Hak, J ^f   Prochazkova D ^g   Cerna Z ^h   Sterba J ^e   Trka, J ^a   Hrusak O ^a   Zuna, J ^a   Mejstrikova E ^a   Janotova I ^a   Sedlacek P ^a   Ptoszkova H ^c   Pospisilova D ^b   Tousovska K ^f   Timr, P ^d   Vavra V ^a   Zdrahalova K ^a   Sramkova L ^a   Zemanova Z ⁱ   Jarosova M ^j   Gajdos P ^a   Hrodek, O ^a   more..

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c Teaching Hospital   (Czech Republic)

^d Regional Hospital   (Czech Republic)

^e UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^f UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^g MASARYK UNIVERSITY   (Czech Republic)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

more..

Author keywords

Acute lymphoblastic leukaemia; children; diagnostics; treatment

Indexed keywords

ASPARAGINASE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILD; CHILD HEALTH CARE; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CZECH REPUBLIC; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG PULSE THERAPY; EVENT FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMAN; INFANT; INTERDISCIPLINARY COMMUNICATION; LEUKEMIA REMISSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT DURATION;

EID: 82055166210     PISSN: 18655041     EISSN: 18655076     Source Type: Journal    
DOI: 10.1007/s12254-011-0289-9     Document Type: Review

References (24)

1. Starý J and Czech Pediatric Hematology Working Group (CPH) 1993 Therapeutic results in children with acute lymphoblastic leukemia in the Czech Republic according to protocol ALL-BFM 83 Čs Pediatr 48 391 397 (In Czech)
2. H Riehm A Reiter M Schrappe, et al. 1986 Die corticosteroid- abhängige Dezimierung der Leukamiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83) Klin Pädiatr 199 151 160 10.1055/s-2008-1026781 (Pubitemid 17079852)
3. M Schrappe A Reiter WD Ludwig, et al. 2000 Improved outcome despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 Blood 95 3310 3322 10828010 1:CAS:528:DC%2BD3cXjsl2isrs%3D (Pubitemid 30428458)
4. J Starý P Gajdoš B Blažek, et al. 2003 Improved outcome in children with acute lymphoblastic leukemia using ALL-BFM 90 study protocol in the Czech Republic Čas Lék čes 142 404 409 (In Czech) (Pubitemid 36975519)
5. J Trka J Zuna C Haškovec, et al. 1999 Detection of hybrid genes BCR-ABL, MLL-AF4 and TEL-AML1 and monitoring of minimal residual disease in children with acute lymphoblastic leukemia Čas Lék čes 138 12 17 1:STN:280:DC%2BD3cvptlOrtw%3D%3D (In Czech)
6. Y Jabali J Starý J Hak, et al. 2000 Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic Med Pediatr Oncol 34 493 495 10.1002/1096-911X(20001101)35:5<493::AID-MPO9>3.0.CO;2-P
7. R Pieters M Schrappe P De Lorenzo, et al. 2007 A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomized trial Lancet 370 240 250 17658395 10.1016/S0140-6736(07)61126-X 1:CAS:528:DC%2BD2sXnvF2gs78%3D (Pubitemid 47082422)
8. A Möricke A Reiter M Zimmermann, et al. 2008 Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95 Blood 111 4477 4489 18285545 10.1182/blood-2007-09-112920
9. V Conter MG Valsecchi D Silvestri, et al. 2007 Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial Lancet 369 123 131 17223475 10.1016/S0140-6736(07)60073-7 1:CAS:528: DC%2BD2sXltVSrtg%3D%3D (Pubitemid 46073131)
10. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481 10.2307/2281868
11. N Mantel 1966 Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 163 170 5910392 1:STN:280:DyaF287ht1Wgug%3D%3D
12. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. John Wiley: New York, pp. 163-188, 1980
13. J Starý P Gajdoš H Hrstková, et al. 2002 Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology MPO 39 125 127
14. J Starý P Gajdoš H Hrstková, et al. 2008 Third consecutive national study ALL-BFM 95 improved the outcome of acute lymphoblastic leukemia in children in the Czech Republic Transfuze Hematol dnes 14 102 109 (In Czech)
15. J Trka J Zuna O Hrušák, et al. 1999 No evidence for MLL/AF4 expression in normal cord blood samples Blood 93 1106 1110 10025980 1:CAS:528:DyaK1MXpsFygtg%3D%3D (Pubitemid 29067877)
16. J Zuna O Hrušák M Kalinová K Muží ková J Starý J Trka 1999 TEL/AML1 positivity in childhood ALL: average or better prognosis Leukemia 13 22 24 10049055 10.1038/sj.leu.2401256 1:STN:280:DyaK1M7jvFyrtQ%3D%3D (Pubitemid 29043712)
17. O Hrušák J Trka J Zuna A Poloučková T Kalina J Starý 2002 Acute lymphoblastic leukemia incidence during socioeconomic transition: selective increase in children from 1 to 4 years Leukemia 16 720 725 11960355 10.1038/sj/leu/2402422 (Pubitemid 34460460)
18. O Krejčí J Starková B Otová, et al. 2004 Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells Leukemia 18 434 441 14724653 10.1038/sj.leu.2403259 (Pubitemid 38425856)
19. L Šrámková K Mužíková E Fraňková, et al. 2007 Detectabe minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia Pediatr Blood Cancer 48 93 100 16521130 10.1002/pbc.20794 (Pubitemid 44871598)
20. E Froňková E Mejstříková S Avigad, et al. 2008 Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing? Leukemia 22 989 997 18305563 10.1038/leu.2008.22 (Pubitemid 351689881)
21. E Mejstříková E Froňková T Kalina, et al. 2010 Detection of residual B precursor lymphoblastic leukemia by uniform gating flow cytometry Pediatr Blood Cancer 54 62 70 19760767 10.1002/pbc.22261
22. E Mejstříková J Volejniková E Fronková, et al. 2010 Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria Haematologica 95 6 928 935 20145275 10.3324/haematol.2009.014506
23. Z Zemanová K Michalová L Šindelář ová, et al. 2005 Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia Leuk Res 29 273 281 15661262 10.1016/j.leukres. 2004.07.004 (Pubitemid 40127053)
24. M Jarošová M Holzerová V Mihál, et al. 2003 Complex karyotypes in childhood acute lymphoblastic leukemia: cytogenetic and molecular cytogenetic study of 21 cases Cancer Genet Cytogenet 145 161 168 12935929 10.1016/S0165-4608(03)00099-2 (Pubitemid 36993748)